Allypth Pharmaceuticals Private Limited
About Allypth Pharmaceuticals Private Limited
Data last updated:
Allypth Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 April 2022.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24290BR2022PTC057394.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pratyush Prasad and Akanksha Anjaneya.
The registered office is at 302 Sushila Residency Anandpuri West Boring Canal Road, Patna, Bihar, India – 800001.
Company details
Contact details
Allypth Pharmaceuticals Private Limited's registered office is in Patna, Bihar.
- Registered Address302 Sushila Residency Anandpuri West Boring Canal Road, Patna, Bihar, India – 800001
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Allypth Pharmaceuticals Private Limited
Year-wise financial statements and ratios of Allypth Pharmaceuticals Private Limited are in the company report Buy the company report.
Board of directors of Allypth Pharmaceuticals Private Limited
Allypth Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratyush Prasad | Director | 11 Apr 2022 | 4 Years 7 Months | Current |
| Akanksha Anjaneya Also directs: Lifin Health Sciences Private Limited | Director | 11 Apr 2022 | 4 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Allypth Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Allypth Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Allypth Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Allypth Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Akanksha Anjaneya was appointed as Director on 11 Apr 2022.
Frequently asked questions
Allypth Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 April 2022 (4+ years old) and is registered under CIN U24290BR2022PTC057394.
Allypth Pharmaceuticals has 2 current directors:
- Pratyush Prasad - Director
- Akanksha Anjaneya - Director
The CIN (Corporate Identification Number) of Allypth Pharmaceuticals is U24290BR2022PTC057394. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Allypth Pharmaceuticals was incorporated on 11 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Patna.
Akanksha Anjaneya was appointed as Director on 11 Apr 2022. Pratyush Prasad was appointed as Director on 11 Apr 2022.
The registered office of Allypth Pharmaceuticals is at 302 Sushila Residency Anandpuri West Boring Canal Road, Patna, Bihar, India – 800001.
Allypth Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Allypth Pharmaceuticals can be reached at its registered office: 302 Sushila Residency Anandpuri West Boring Canal Road, Patna, Bihar, India – 800001.
Allypth Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Patna.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
